Clinical studies recruiting near Pontiac

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Trinity Health Saint Joseph Mercy Oakland Hospital · National Cancer Institute (NCI) · NCT05564390 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Michigan Healthcare Professionals Pontiac · NRG Oncology · NCT05624996 Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A Myel
Phase 2 · Trinity Health Saint Joseph Mercy Oakland Hospital · National Cancer Institute (NCI) · NCT07437950 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Trinity Health Saint Joseph Mercy Oakland Hospital · Alliance for Clinical Trials in Oncology · NCT07321652 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Hope Cancer Center · Alliance for Clinical Trials in Oncology · NCT07091617 Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · Trinity Health Saint Joseph Mercy Oakland Hospital · SWOG Cancer Research Network · NCT06769126 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Elixia Health - Michigan Kidney Consultants, LLC - Elixia - · Biogen · NCT06962800 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Hope Cancer Center · NRG Oncology · NCT05174169 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Trinity Health Saint Joseph Mercy Oakland Hospital · Alliance for Clinical Trials in Oncology · NCT06931340 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · Elixia MKC · Takeda · NCT06963827 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Hope Cancer Center · Alliance for Clinical Trials in Oncology · NCT06876714 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Hope Cancer Center · National Cancer Institute (NCI) · NCT04269902 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Trinity Health Saint Joseph Mercy Oakland Hospital · NRG Oncology · NCT06748222 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Hope Cancer Center · Alliance for Clinical Trials in Oncology · NCT04242095 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Trinity Health Saint Joseph Mercy Oakland Hospital · National Cancer Institute (NCI) · NCT05256225 Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidin
Phase 2 · Trinity Health Saint Joseph Mercy Oakland Hospital · National Cancer Institute (NCI) · NCT05554393 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · Trinity Health Saint Joseph Mercy Oakland Hospital · National Cancer Institute (NCI) · NCT06498635 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Hope Cancer Center · ECOG-ACRIN Cancer Research Group · NCT04566328 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Michigan Healthcare Professionals Pontiac · NRG Oncology · NCT04852887 Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Phase N/A · Trinity Health Saint Joseph Mercy Oakland Hospital · Wake Forest University Health Sciences · NCT03998202 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Hope Cancer Center · Alliance for Clinical Trials in Oncology · NCT05677490 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With
Phase 3 · Trinity Health Saint Joseph Mercy Oakland Hospital · National Cancer Institute (NCI) · NCT07198074 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Trinity Health Saint Joseph Mercy Oakland Hospital · National Cancer Institute (NCI) · NCT06058377 Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin
Phase 2 · Trinity Health Saint Joseph Mercy Oakland Hospital · National Cancer Institute (NCI) · NCT06917911 An Internet-based Program to Help Cancer Survivors Manage Pain
NA · Trinity Health Saint Joseph Mercy Oakland Hospital · Wake Forest University Health Sciences · NCT04462302 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Phase N/A · Hope Cancer Center · ECOG-ACRIN Cancer Research Group · NCT04239573 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Trinity Health Saint Joseph Mercy Oakland Hospital · National Cancer Institute (NCI) · NCT05987241 Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The Co
Phase 2 · Michigan Healthcare Professionals Pontiac · National Cancer Institute (NCI) · NCT05564377 Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Phase 2 · Hope Cancer Center · SWOG Cancer Research Network · NCT04205968 Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Trea
Phase 2 · Trinity Health Saint Joseph Mercy Oakland Hospital · National Cancer Institute (NCI) · NCT06317649

Look up another city

Look up another condition